Fred E. Cohen - 03 Nov 2026 Form 4 Insider Report for CareDx, Inc. (CDNA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Nov 2026, 16:05:09 UTC
Prior SEC filing
16 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey Adam Novack, Attorney-in-Fact
Filing notes and source

Key filing fact

Fred E. Cohen filed Form 4 for CareDx, Inc. (CDNA) on 04 Nov 2026.

Key facts

  • This page summarizes Fred E. Cohen's Form 4 filing for CareDx, Inc. (CDNA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Nov 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 16 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001339358 Primary reporting owner

Cohen Fred E

Relationship
Director
Address
C/O CAREDX, INC., 8000 MARINA BOULEVARD, 4TH FLOOR, BRISBANE
Signature
/s/ Jeffrey Adam Novack, Attorney-in-Fact
Signature date
03 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDNA transaction

Common Stock

Gift

Transaction value
Shares
-25,000
Change %
-15%
Price
$0.000000*
Shares after
140,060
Date
03 Nov 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .